Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman Represents Digital Brands Group in Successful Uplisting to Nasdaq

Digital Brands Group, Inc. (NASDAQ: DBGI), a publicly traded leader in eCommerce and fashion, has commenced trading on The Nasdaq Capital Market…

Read More

Lucosky Brookman LLP Represents ALT5 Sigma Corporation in $1.5 Billion Registered Direct Offering and Concurrent Private Placement

ALT5 Sigma Corporation (NASDAQ: ALTS)(FRA: 5AR1), a fintech innovator delivering next-generation blockchain-powered solutions for…

Read More

Lucosky Brookman LLP Represents Digital Brands Group in $11.225 Million Private Placement

Digital Brands Group, Inc. (OTCQX: DBGI), a publicly traded eCommerce and fashion company, has entered into a securities purchase agreement…

Read More

Lucosky Brookman LLP Represents Titan Partners Group as Sole Placement Agent in $15 Million Registered Direct Offering for Belite Bio

Lucosky Brookman LLP represented Titan Partners Group, a division of American Capital Partners, as sole placement agent in a $15 million…

Read More

Lucosky Brookman LLP Advises Brag House Holdings, Inc. on $15 Million PIPE Financing to Support Strategic Expansion

Brag House Holdings, Inc. (NASDAQ: TBH), the Gen Z-focused engagement platform operating at the intersection of gaming, college sports, and…

Read More

Capstone Holding Corp. Closes $10 Million Convertible Note Facility to Support M&A Strategy

Capstone Holding Corp. (Nasdaq: CAPS), a national building products distribution platform, has closed a previously announced $10 million…

Read More

Lucosky Brookman LLP Advises Tharimmune, Inc. on Closing of $1.74 Million Registered Direct Offering

Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company focused on advancing therapies in immunology and inflammation,…

Read More

iSpecimen Closes $4 Million Underwritten Offering; Lucosky Brookman LLP Serves as Counsel to WestPark Capital

iSpecimen Inc. (Nasdaq: ISPC), an online marketplace connecting medical researchers with human biospecimens, has closed its previously…

Read More

Tron Inc. Rings Nasdaq Opening Bell Following $100 Million TRON Token Transaction

Tron Inc. (NASDAQ: TRON), a defining moment at Nasdaq today with H.E. Justin Sun, founder of the TRON DAO blockchain, ringing the opening bell…

Read More

Lucosky Brookman Represents Safety Shot in $16.3 Million Registered Direct Offering and Private Placement

Safety Shot, Inc. (Nasdaq: SHOT), a wellness and dietary supplement company, has closed its previously announced $16.3 million financing,…

Read More